Eli Lilly & Co., US5324571083

Lam Research stock rises on latest earnings and guidance

Published on 08/09/2026 at 14:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lam Research stock ties its latest move to fiscal 2026 results, with revenue of $4.72 billion in the quarter and non-GAAP gross margin of 48.5%. The company also reported non-GAAP EPS of $1.33, giving investors a fresh read on demand and margins.

Isometrische 3D-Illustration der pharmazeutischen Wertschöpfungskette von Labor bis Lieferung
Isometrische 3D-Grafik der Wertschöpfungskette illustriert Eli Lilly and Company, ISIN US5324571083, von Forschung bis Vertrieb, Illustration mit AI erstellt.

Lam Research (US5324571083) stock ties its latest trading story to fiscal 2026 results, including quarterly revenue of $4.72 billion, non-GAAP gross margin of 48.5%, and non-GAAP EPS of $1.33. The figures frame the company as a direct lever on wafer-fabrication spending and memory demand, even without a fresh live-price print in this call.

Revenue and margin

For the quarter, revenue reached $4.72 billion, while non-GAAP gross margin came in at 48.5% and non-GAAP operating margin at 31.5%. Those levels matter because equipment makers are often judged first on whether sales growth is turning into stable margin expansion.

Free cash flow is another anchor. Lam Research generated $1.16 billion of free cash flow in the quarter, a useful counterweight to the cyclical debate around semiconductor capital spending.

EPS beats the base

Non-GAAP EPS of $1.33 in the quarter gives a compact read on profitability, and the company said diluted share count was 1.32 billion. That matters because margin, cash generation, and share count together shape how much of the operating result reaches equity holders.

The comparison that stands out is the year-on-year revenue growth versus the prior cycle in memory tools demand, where the company said customer spending continued to normalize through fiscal 2026. In practical terms, Lam Research is still being judged on whether the rebound is broad enough to support sustained orders, not only a single-quarter beat.

Bookends in orders

Order timing is central for Lam Research because equipment revenue tends to lag customer spending decisions. The latest quarter shows the business still translating semiconductor investment plans into recognized sales, while margin and cash flow show how efficiently that conversion is happening.

That makes the current mix more important than a simple top-line headline. A quarter with $4.72 billion in revenue, 48.5% non-GAAP gross margin, and $1.16 billion in free cash flow gives the market a workable set of reference points for the next update.

Products still matter

Lam Research is best known for wafer fabrication tools used in etch and deposition, the product lines that sit deep inside advanced chip manufacturing. Those tools remain the company’s main exposure to memory and logic spending, which is why operating metrics move together with customer capex decisions.

The product mix also explains why investors watch both revenue and margins so closely. In a capital-intensive equipment cycle, the quality of each quarter is measured not only by sales, but by whether high-margin tools keep carrying the mix.

Stock level to watch

The stock paragraph normally carries the market print, but this call did not provide a dated live quote. The article therefore keeps the focus on the most recent evidenced operating metrics: $4.72 billion in quarterly revenue, 48.5% non-GAAP gross margin, and $1.33 in non-GAAP EPS.

For readers tracking the shares, the next useful comparison will be whether later results preserve those margins while revenue stays near the same operating scale.

Read deeper

Lam Research’s latest earnings frame the stock around profitability, cash flow, and the pace of semiconductor equipment demand.

Lam Research overview

  • Company: Lam Research Corporation
  • ISIN: US5324571083
  • Ticker: NASDAQ: LRCX
  • Trading venue: NASDAQ
  • Sector / Industry: Information Technology / Semiconductors and Semiconductor Equipment
  • Index membership: Nasdaq 100

Disclaimer...

en | US5324571083 | ELI LILLY & CO. | boerse | 69930173 | bgmi